Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals

episode

Blood & Cancer not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Episode 5675: Peter Navarro Live In Studio 54 min · 19 Sep 2026 · Bannon`s War Room

NPR News: 09-19-2026 1PM EDT 4 min · 19 Sep 2026 · NPR News Now

President Trump is set to join world leaders at the United Nations General Assembly next week in New York City. 3 min · 19 Sep 2026 · Fox News Hourly Update

OPENLINE | SATURDAY 19TH SEPTEMBER 43 min · 19 Sep 2026 · Superscoreboard

LIVE SCOTTISH FOOTBALL | SATURDAY 19TH SEPTEMBER 2h 37m · 19 Sep 2026 · Superscoreboard

Live From London (Night 1) | Reading Reddit Stories 1h 29m · 19 Sep 2026 · Smosh Reads Reddit Stories

Report any issue

Source

Recorded11 Aug 2020

Publisherjcsopodcast.libsyn.com ↗

Handlerec:14215297

Show notes

Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc news: Study: Immune checkpoint inhibitors don't increase risk of death in cancer patients with COVID-19: https://bit.ly/2PEttQa System provides 'faster, less invasive' method for breast cancer detection: https://bit.ly/3achral Source: https://bit.ly/3gN507j FDA approves belantamab in relapsed/refractory multiple myeloma: https://bit.ly/3ksQtQu FDA approves new drug for diffuse large B-cell lymphoma: https://bit.ly/3kvoIXn For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52 Email the show: [email protected] Follow Dr. David Henry on Twitter @DavidHenryMD

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in